Zomedica Announces Third Quarter 2025 Financial Results: Revenue up 16% to $8.1 Million with 67% Gross Margins and $54 Million in Liquidity to Support Growth

Core Insights - Zomedica reported its highest quarterly revenue ever for the third quarter ended September 30, 2025, marking a record year-over-year revenue for the 19th consecutive quarter [1] Financial Performance - The company achieved significant financial growth, with consolidated financial results indicating a strong performance in the animal health sector [1] - The report highlights the effectiveness of Zomedica's point-of-care diagnostic and therapeutic products for equine and companion animals, contributing to the revenue increase [1]